X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2025-01-24 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $90.00 | -12,437 | 40,979 | -23% | -$1,119,330 | |||||
D | 2025-01-08 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $80.41 | -9,850 | 40,708 | -19% | -$792,039 | |||||
D | 2024-06-07 | MDT | Martha Geoffrey | COB, CEO | S - Sale+OE | $83.77 | -19,113 | 143,348 | -12% | -$1,601,001 | |||||
2024-04-08 | MDT | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale | $83.14 | -854 | 27,925 | -3% | -$71,002 | ||||||
D | 2024-02-21 | MDT | Salmon Sean | EVP, Pres Cardiovascular | S - Sale+OE | $85.13 | -30,695 | 48,289 | -39% | -$2,613,055 | |||||
2023-12-19 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale | $82.17 | -4,997 | 28,910 | -15% | -$410,603 | ||||||
2023-08-23 | MDT | Smith Gregory L | EVP Global Ops, Supply Chain | S - Sale | $83.84 | -10,000 | 46,723 | -18% | -$838,400 | ||||||
2023-08-14 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale | $83.38 | -1,000 | 33,573 | -3% | -$83,380 | ||||||
D | 2023-08-04 | MDT | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale+OE | $84.11 | -1,352 | 28,930 | -4% | -$113,717 | |||||
2023-07-14 | MDT | Wall Brett A. | EVP, Pres Neuroscience | S - Sale | $87.97 | -2,000 | 23,948 | -8% | -$175,940 | ||||||
D | 2023-07-10 | MDT | Ten Hoedt Rob | EVP, Pres Global Regions | S - Sale+OE | $86.58 | -5,514 | 43,802 | -11% | -$477,420 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |